ID   AOFA_HUMAN              Reviewed;         527 AA.
AC   P21397; B4DF46; Q16426;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1991, sequence version 1.
DT   12-APR-2017, entry version 195.
DE   RecName: Full=Amine oxidase [flavin-containing] A;
DE            EC=1.4.3.4;
DE   AltName: Full=Monoamine oxidase type A;
DE            Short=MAO-A;
GN   Name=MAOA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3418353; DOI=10.1111/j.1471-4159.1988.tb03105.x;
RA   Hsu Y.-P.P., Weyler W., Chen S., Sims K.B., Rinehart W.B.,
RA   Utterback M.C., Powell J.F., Breakefield X.O.;
RT   "Structural features of human monoamine oxidase A elucidated from cDNA
RT   and peptide sequences.";
RL   J. Neurochem. 51:1321-1324(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=3387449; DOI=10.1073/pnas.85.13.4934;
RA   Bach A.W.J., Lan N.C., Johnson D.L., Abell C.W., Bembenek M.E.,
RA   Kwan S.W., Seeburg P.H., Shih J.C.;
RT   "cDNA cloning of human liver monoamine oxidase A and B: molecular
RT   basis of differences in enzymatic properties.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:4934-4938(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1886775; DOI=10.1093/nar/19.16.4537;
RA   Chen Z.-Y., Hotamisligil G.S., Huang J.-K., Wen L., Ezzeddine D.,
RA   Aydin-Muderrisoglu N., Powell J.F., Huang R.H., Breakefield X.O.,
RA   Craig I., Hsu Y.-P.P.;
RT   "Structure of the human gene for monoamine oxidase type A.";
RL   Nucleic Acids Res. 19:4537-4541(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2023912; DOI=10.1073/pnas.88.9.3637;
RA   Grimsby J., Chen K., Wang L.J., Lan N.C., Shih J.C.;
RT   "Human monoamine oxidase A and B genes exhibit identical exon-intron
RT   organization.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:3637-3641(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-24.
RX   PubMed=1432104;
RA   Zhu Q.S., Grimsby J.S., Chen K., Shih J.C.;
RT   "Promoter organization and activity of human monoamine oxidase (MAO) A
RT   and B genes.";
RL   J. Neurosci. 12:4437-4446(1992).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-27.
RX   PubMed=8584674;
RA   Denney R.M.;
RT   "The promoter of the human monoamine oxidase A gene.";
RL   Prog. Brain Res. 106:57-66(1995).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-33.
RX   PubMed=7519662;
RA   Denney R.M., Sharma A., Dave S.K., Waguespack A.;
RT   "A new look at the promoter of the human monoamine oxidase A gene:
RT   mapping transcription initiation sites and capacity to drive
RT   luciferase expression.";
RL   J. Neurochem. 63:843-856(1994).
RN   [11]
RP   PROTEIN SEQUENCE OF 31-45; 62-78; 109-129; 268-288; 298-315; 318-332;
RP   336-352; 372-412; 430-440 AND 458-493.
RC   TISSUE=Placenta;
RX   PubMed=3178846; DOI=10.1016/S0006-291X(88)80861-1;
RA   Chen S.-Y., Weyler W.;
RT   "Partial amino acid sequence analysis of human placenta monoamine
RT   oxidase A and bovine liver monoamine oxidase B.";
RL   Biochem. Biophys. Res. Commun. 156:445-450(1988).
RN   [12]
RP   DETERMINATION OF PROTEIN-FAD RATIO.
RC   TISSUE=Placenta;
RX   PubMed=2764901; DOI=10.1042/bj2600725;
RA   Weyler W.;
RT   "Monoamine oxidase A from human placenta and monoamine oxidase B from
RT   bovine liver both have one FAD per subunit.";
RL   Biochem. J. 260:725-729(1989).
RN   [13]
RP   PARTIAL PROTEIN SEQUENCE, ACETYLATION AT MET-1, AND MASS SPECTROMETRY.
RX   PubMed=11812236; DOI=10.1006/prep.2001.1546;
RA   Li M., Hubalek F., Newton-Vinson P., Edmondson D.E.;
RT   "High-level expression of human liver monoamine oxidase A in Pichia
RT   pastoris: comparison with the enzyme expressed in Saccharomyces
RT   cerevisiae.";
RL   Protein Expr. Purif. 24:152-162(2002).
RN   [14]
RP   MUTAGENESIS OF CYS-165; CYS-266; CYS-306; CYS-321; CYS-323; CYS-374;
RP   CYS-398 AND CYS-406.
RX   PubMed=8316221;
RA   Wu H.F., Chen K., Shih J.C.;
RT   "Site-directed mutagenesis of monoamine oxidase A and B: role of
RT   cysteines.";
RL   Mol. Pharmacol. 43:888-893(1993).
RN   [15]
RP   INVOLVEMENT IN BRNRS.
RX   PubMed=8211186; DOI=10.1126/science.8211186;
RA   Brunner H.G., Nelen M., Breakefield X.O., Ropers H.-H., van Oost B.A.;
RT   "Abnormal behavior associated with a point mutation in the structural
RT   gene for monoamine oxidase A.";
RL   Science 262:578-580(1993).
RN   [16]
RP   POLYMORPHISM IN THE PROMOTER REGION.
RX   PubMed=9799080; DOI=10.1007/s004390050816;
RA   Sabol S.Z., Hu S., Hamer D.;
RT   "A functional polymorphism in the monoamine oxidase A gene promoter.";
RL   Hum. Genet. 103:273-279(1998).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS), COFACTOR, AND SUBUNIT.
RX   PubMed=16129825; DOI=10.1073/pnas.0505975102;
RA   De Colibus L., Li M., Binda C., Lustig A., Edmondson D.E., Mattevi A.;
RT   "Three-dimensional structure of human monoamine oxidase A (MAO A):
RT   relation to the structures of rat MAO A and human MAO B.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:12684-12689(2005).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.17 ANGSTROMS) OF 12-524 IN COMPLEX WITH FAD
RP   AND THE INHIBITOR HARMINE, COFACTOR, AND TOPOLOGY.
RX   PubMed=18391214; DOI=10.1073/pnas.0710626105;
RA   Son S.-Y., Ma J., Kondou Y., Yoshimura M., Yamashita E., Tsukihara T.;
RT   "Structure of human monoamine oxidase A at 2.2-A resolution: the
RT   control of opening the entry for substrates/inhibitors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:5739-5744(2008).
RN   [20]
RP   VARIANT [LARGE SCALE ANALYSIS] GLU-15.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [21]
RP   VARIANT LYS-188.
RX   PubMed=21179162; DOI=10.1038/nature09629;
RA   Bevilacqua L., Doly S., Kaprio J., Yuan Q., Tikkanen R., Paunio T.,
RA   Zhou Z., Wedenoja J., Maroteaux L., Diaz S., Belmer A.,
RA   Hodgkinson C.A., Dell'osso L., Suvisaari J., Coccaro E., Rose R.J.,
RA   Peltonen L., Virkkunen M., Goldman D.;
RT   "A population-specific HTR2B stop codon predisposes to severe
RT   impulsivity.";
RL   Nature 468:1061-1066(2010).
RN   [22]
RP   VARIANT PHE-266, AND CHARACTERIZATION OF VARIANT PHE-266.
RX   PubMed=24169519; DOI=10.1038/ejhg.2013.243;
RA   Piton A., Poquet H., Redin C., Masurel A., Lauer J., Muller J.,
RA   Thevenon J., Herenger Y., Chancenotte S., Bonnet M., Pinoit J.M.,
RA   Huet F., Thauvin-Robinet C., Jaeger A.S., Le Gras S., Jost B.,
RA   Gerard B., Peoc'h K., Launay J.M., Faivre L., Mandel J.L.;
RT   "20 ans apres: a second mutation in MAOA identified by targeted high-
RT   throughput sequencing in a family with altered behavior and
RT   cognition.";
RL   Eur. J. Hum. Genet. 22:776-783(2014).
CC   -!- FUNCTION: Catalyzes the oxidative deamination of biogenic and
CC       xenobiotic amines and has important functions in the metabolism of
CC       neuroactive and vasoactive amines in the central nervous system
CC       and peripheral tissues. MAOA preferentially oxidizes biogenic
CC       amines such as 5-hydroxytryptamine (5-HT), norepinephrine and
CC       epinephrine.
CC   -!- CATALYTIC ACTIVITY: RCH(2)NHR' + H(2)O + O(2) = RCHO + R'NH(2) +
CC       H(2)O(2).
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:16129825,
CC         ECO:0000269|PubMed:18391214};
CC   -!- SUBUNIT: Monomer, homo- or heterodimer (containing two subunits of
CC       similar size). Each subunit contains a covalently bound flavin.
CC       Enzymatically active as monomer. {ECO:0000269|PubMed:16129825,
CC       ECO:0000269|PubMed:18391214}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane; Single-pass
CC       type IV membrane protein; Cytoplasmic side.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P21397-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P21397-2; Sequence=VSP_045173;
CC   -!- TISSUE SPECIFICITY: Heart, liver, duodenum, blood vessels and
CC       kidney.
CC   -!- MASS SPECTROMETRY: Mass=60512; Mass_error=6; Method=Electrospray;
CC       Range=1-527; Evidence={ECO:0000269|PubMed:11812236};
CC   -!- POLYMORPHISM: A polymorphism 1.2 kb upstream of the MAOA coding
CC       sequences consists of a 30-bp repeated sequence present in 3, 3.5,
CC       4, or 5 copies. The polymorphism affect transcriptional activity
CC       of the MAOA gene promoter. Alleles with 3.5 or 4 copies of the
CC       repeat sequence are transcribed 2 to 10 times more efficiently
CC       than those with 3 or 5 copies of the repeat.
CC   -!- DISEASE: Brunner syndrome (BRNRS) [MIM:300615]: A form of X-linked
CC       non-dysmorphic mild mental retardation. Male patients are affected
CC       by borderline mental retardation and exhibit abnormal behavior,
CC       including disturbed regulation of impulsive aggression. Obligate
CC       female carriers have normal intelligence and behavior.
CC       {ECO:0000269|PubMed:8211186}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the flavin monoamine oxidase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Monoamine oxidase entry;
CC       URL="https://en.wikipedia.org/wiki/Monoamine_oxidase";
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Approaching happiness -
CC       Issue 172 of August 2015;
CC       URL="http://web.expasy.org/spotlight/back_issues/172/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M69226; AAA59549.1; -; mRNA.
DR   EMBL; M68840; AAA59548.1; -; mRNA.
DR   EMBL; X60806; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X60807; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X60808; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X60809; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X60810; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X60811; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X60812; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X60813; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X60814; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X60815; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X60816; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X60817; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X60818; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X60819; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M68857; AAA59547.1; -; Genomic_DNA.
DR   EMBL; M68843; AAA59547.1; JOINED; Genomic_DNA.
DR   EMBL; M68844; AAA59547.1; JOINED; Genomic_DNA.
DR   EMBL; M68845; AAA59547.1; JOINED; Genomic_DNA.
DR   EMBL; M68846; AAA59547.1; JOINED; Genomic_DNA.
DR   EMBL; M68847; AAA59547.1; JOINED; Genomic_DNA.
DR   EMBL; M68848; AAA59547.1; JOINED; Genomic_DNA.
DR   EMBL; M68849; AAA59547.1; JOINED; Genomic_DNA.
DR   EMBL; M68850; AAA59547.1; JOINED; Genomic_DNA.
DR   EMBL; M68851; AAA59547.1; JOINED; Genomic_DNA.
DR   EMBL; M68852; AAA59547.1; JOINED; Genomic_DNA.
DR   EMBL; M68853; AAA59547.1; JOINED; Genomic_DNA.
DR   EMBL; M68854; AAA59547.1; JOINED; Genomic_DNA.
DR   EMBL; M68855; AAA59547.1; JOINED; Genomic_DNA.
DR   EMBL; M68856; AAA59547.1; JOINED; Genomic_DNA.
DR   EMBL; AK293926; BAG57307.1; -; mRNA.
DR   EMBL; AL109855; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX530072; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX537147; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX537148; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC008064; AAH08064.1; -; mRNA.
DR   EMBL; M89636; AAB46385.1; -; Genomic_DNA.
DR   EMBL; S81371; AAD14361.1; -; Genomic_DNA.
DR   EMBL; S72704; AAD14113.1; -; Genomic_DNA.
DR   CCDS; CCDS14260.1; -. [P21397-1]
DR   CCDS; CCDS59163.1; -. [P21397-2]
DR   PIR; A36175; A36175.
DR   RefSeq; NP_000231.1; NM_000240.3. [P21397-1]
DR   RefSeq; NP_001257387.1; NM_001270458.1. [P21397-2]
DR   UniGene; Hs.183109; -.
DR   PDB; 1H8Q; Model; -; A=14-468.
DR   PDB; 2BXR; X-ray; 3.00 A; A/B=1-527.
DR   PDB; 2BXS; X-ray; 3.15 A; A/B=1-527.
DR   PDB; 2Z5X; X-ray; 2.20 A; A=12-524.
DR   PDB; 2Z5Y; X-ray; 2.17 A; A=12-524.
DR   PDBsum; 1H8Q; -.
DR   PDBsum; 2BXR; -.
DR   PDBsum; 2BXS; -.
DR   PDBsum; 2Z5X; -.
DR   PDBsum; 2Z5Y; -.
DR   ProteinModelPortal; P21397; -.
DR   SMR; P21397; -.
DR   BioGrid; 110301; 4.
DR   IntAct; P21397; 2.
DR   MINT; MINT-4054607; -.
DR   STRING; 9606.ENSP00000340684; -.
DR   BindingDB; P21397; -.
DR   ChEMBL; CHEMBL1951; -.
DR   DrugBank; DB01472; 4-Methoxyamphetamine.
DR   DrugBank; DB07919; 7-METHOXY-1-METHYL-9H-BETA-CARBOLINE.
DR   DrugBank; DB00918; Almotriptan.
DR   DrugBank; DB00182; Amphetamine.
DR   DrugBank; DB01445; Bufotenine.
DR   DrugBank; DB06774; Capsaicin.
DR   DrugBank; DB05205; CX157.
DR   DrugBank; DB07641; DECYL(DIMETHYL)PHOSPHINE OXIDE.
DR   DrugBank; DB00988; Dopamine.
DR   DrugBank; DB01363; Ephedra.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB00614; Furazolidone.
DR   DrugBank; DB01247; Isocarboxazid.
DR   DrugBank; DB00601; Linezolid.
DR   DrugBank; DB01577; Methamphetamine.
DR   DrugBank; DB00805; Minaprine.
DR   DrugBank; DB01442; MMDA.
DR   DrugBank; DB01171; Moclobemide.
DR   DrugBank; DB08804; Nandrolone decanoate.
DR   DrugBank; DB00952; Naratriptan.
DR   DrugBank; DB04820; Nialamide.
DR   DrugBank; DB00184; Nicotine.
DR   DrugBank; DB04821; Nomifensine.
DR   DrugBank; DB06412; Oxymetholone.
DR   DrugBank; DB01626; Pargyline.
DR   DrugBank; DB00780; Phenelzine.
DR   DrugBank; DB00191; Phentermine.
DR   DrugBank; DB00388; Phenylephrine.
DR   DrugBank; DB00397; Phenylpropanolamine.
DR   DrugBank; DB04850; Posizolid.
DR   DrugBank; DB00721; Procaine.
DR   DrugBank; DB01168; Procarbazine.
DR   DrugBank; DB00852; Pseudoephedrine.
DR   DrugBank; DB00140; Riboflavin.
DR   DrugBank; DB00953; Rizatriptan.
DR   DrugBank; DB01037; Selegiline.
DR   DrugBank; DB01104; Sertraline.
DR   DrugBank; DB00669; Sumatriptan.
DR   DrugBank; DB00624; Testosterone.
DR   DrugBank; DB00752; Tranylcypromine.
DR   DrugBank; DB04832; Zimelidine.
DR   DrugBank; DB00315; Zolmitriptan.
DR   DrugBank; DB00909; Zonisamide.
DR   GuidetoPHARMACOLOGY; 2489; -.
DR   iPTMnet; P21397; -.
DR   PhosphoSitePlus; P21397; -.
DR   SwissPalm; P21397; -.
DR   BioMuta; MAOA; -.
DR   DMDM; 113978; -.
DR   EPD; P21397; -.
DR   PaxDb; P21397; -.
DR   PeptideAtlas; P21397; -.
DR   PRIDE; P21397; -.
DR   DNASU; 4128; -.
DR   Ensembl; ENST00000338702; ENSP00000340684; ENSG00000189221. [P21397-1]
DR   Ensembl; ENST00000542639; ENSP00000440846; ENSG00000189221. [P21397-2]
DR   GeneID; 4128; -.
DR   KEGG; hsa:4128; -.
DR   UCSC; uc011mkw.3; human. [P21397-1]
DR   CTD; 4128; -.
DR   DisGeNET; 4128; -.
DR   GeneCards; MAOA; -.
DR   HGNC; HGNC:6833; MAOA.
DR   HPA; CAB009437; -.
DR   HPA; HPA054807; -.
DR   HPA; HPA059299; -.
DR   MalaCards; MAOA; -.
DR   MIM; 300615; phenotype.
DR   MIM; 309850; gene.
DR   neXtProt; NX_P21397; -.
DR   OpenTargets; ENSG00000189221; -.
DR   Orphanet; 3057; Monoamine oxidase A deficiency.
DR   PharmGKB; PA236; -.
DR   eggNOG; KOG0029; Eukaryota.
DR   eggNOG; ENOG410XSNC; LUCA.
DR   GeneTree; ENSGT00730000110903; -.
DR   HOGENOM; HOG000221615; -.
DR   HOVERGEN; HBG004255; -.
DR   InParanoid; P21397; -.
DR   KO; K00274; -.
DR   OMA; DAPWEAP; -.
DR   OrthoDB; EOG091G0G7P; -.
DR   PhylomeDB; P21397; -.
DR   TreeFam; TF313314; -.
DR   BioCyc; MetaCyc:HS01798-MONOMER; -.
DR   BRENDA; 1.4.3.4; 2681.
DR   Reactome; R-HSA-141333; Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB.
DR   Reactome; R-HSA-181430; Norepinephrine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-379397; Enzymatic degradation of dopamine by COMT.
DR   Reactome; R-HSA-379398; Enzymatic degradation of Dopamine by monoamine oxidase.
DR   Reactome; R-HSA-380612; Metabolism of serotonin.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   SABIO-RK; P21397; -.
DR   ChiTaRS; MAOA; human.
DR   EvolutionaryTrace; P21397; -.
DR   GeneWiki; Monoamine_oxidase_A; -.
DR   GenomeRNAi; 4128; -.
DR   PRO; PR:P21397; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000189221; -.
DR   CleanEx; HS_MAOA; -.
DR   ExpressionAtlas; P21397; baseline and differential.
DR   Genevisible; P21397; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005741; C:mitochondrial outer membrane; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0008131; F:primary amine oxidase activity; TAS:Reactome.
DR   GO; GO:0006576; P:cellular biogenic amine metabolic process; TAS:ProtInc.
DR   GO; GO:0042420; P:dopamine catabolic process; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0042135; P:neurotransmitter catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0042133; P:neurotransmitter metabolic process; TAS:Reactome.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR001613; Flavin_amine_oxidase.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   PRINTS; PR00757; AMINEOXDASEF.
DR   SUPFAM; SSF51905; SSF51905; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Catecholamine metabolism; Complete proteome;
KW   Direct protein sequencing; Disease mutation; FAD; Flavoprotein;
KW   Membrane; Mental retardation; Mitochondrion;
KW   Mitochondrion outer membrane; Neurotransmitter degradation;
KW   Oxidoreductase; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    527       Amine oxidase [flavin-containing] A.
FT                                /FTId=PRO_0000099850.
FT   TOPO_DOM      1    497       Cytoplasmic.
FT                                {ECO:0000269|PubMed:18391214}.
FT   TRANSMEM    498    518       Helical; Anchor for type IV membrane
FT                                protein.
FT   TOPO_DOM    519    527       Mitochondrial intermembrane.
FT                                {ECO:0000269|PubMed:18391214}.
FT   REGION      520    522       Interaction with membrane phospholipid
FT                                headgroups. {ECO:0000305}.
FT   SITE        335    335       Important for substrate specificity.
FT                                {ECO:0000250}.
FT   SITE        374    374       Important for catalytic activity.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000269|PubMed:11812236}.
FT   MOD_RES     383    383       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P21396}.
FT   MOD_RES     406    406       S-8alpha-FAD cysteine.
FT   VAR_SEQ       1    133       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045173.
FT   VARIANT      15     15       D -> E (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036545.
FT   VARIANT     188    188       E -> K (in dbSNP:rs77698881).
FT                                {ECO:0000269|PubMed:21179162}.
FT                                /FTId=VAR_064573.
FT   VARIANT     266    266       C -> F (probable disease-associated
FT                                mutation found in a family with Brunner
FT                                syndrome-like behavioral disturbances;
FT                                reduced activity; dbSNP:rs587777457).
FT                                {ECO:0000269|PubMed:24169519}.
FT                                /FTId=VAR_071963.
FT   VARIANT     314    314       F -> V (in dbSNP:rs1799835).
FT                                /FTId=VAR_014795.
FT   VARIANT     520    520       K -> R (in dbSNP:rs1800466).
FT                                /FTId=VAR_014796.
FT   MUTAGEN     165    165       C->S: No loss of activity.
FT                                {ECO:0000269|PubMed:8316221}.
FT   MUTAGEN     266    266       C->S: No loss of activity.
FT                                {ECO:0000269|PubMed:8316221}.
FT   MUTAGEN     306    306       C->S: No loss of activity.
FT                                {ECO:0000269|PubMed:8316221}.
FT   MUTAGEN     321    321       C->S: No loss of activity.
FT                                {ECO:0000269|PubMed:8316221}.
FT   MUTAGEN     323    323       C->S: No loss of activity.
FT                                {ECO:0000269|PubMed:8316221}.
FT   MUTAGEN     374    374       C->S: Complete loss of activity.
FT                                {ECO:0000269|PubMed:8316221}.
FT   MUTAGEN     398    398       C->S: No loss of activity.
FT                                {ECO:0000269|PubMed:8316221}.
FT   MUTAGEN     406    406       C->S: Complete loss of activity.
FT                                {ECO:0000269|PubMed:8316221}.
FT   CONFLICT    397    397       W -> M (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       15     19       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX        23     34       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND       39     42       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND       44     49       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND       54     57       {ECO:0000244|PDB:2Z5X}.
FT   TURN         58     60       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND       61     66       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX        75     83       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND       88     90       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND       94    101       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      104    108       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      110    112       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       118    136       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       143    145       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       149    154       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       157    164       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       168    182       {ECO:0000244|PDB:2Z5Y}.
FT   TURN        186    188       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       191    199       {ECO:0000244|PDB:2Z5Y}.
FT   TURN        200    202       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       204    208       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      211    213       {ECO:0000244|PDB:2BXS}.
FT   STRAND      216    219       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       224    234       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       235    237       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      238    241       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      244    248       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      250    258       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      263    271       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       275    278       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      281    285       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       289    295       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      303    309       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       314    317       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      320    327       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      334    338       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      348    354       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       355    361       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       366    381       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       385    387       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      390    397       {ECO:0000244|PDB:2Z5Y}.
FT   TURN        401    403       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      405    407       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       415    418       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       420    422       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      430    432       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       435    437       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      439    441       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       445    462       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      464    466       {ECO:0000244|PDB:2BXS}.
FT   HELIX       469    471       {ECO:0000244|PDB:2Z5Y}.
FT   STRAND      479    481       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       490    494       {ECO:0000244|PDB:2Z5Y}.
FT   HELIX       498    520       {ECO:0000244|PDB:2Z5Y}.
SQ   SEQUENCE   527 AA;  59682 MW;  4270E346928AE832 CRC64;
     MENQEKASIA GHMFDVVVIG GGISGLSAAK LLTEYGVSVL VLEARDRVGG RTYTIRNEHV
     DYVDVGGAYV GPTQNRILRL SKELGIETYK VNVSERLVQY VKGKTYPFRG AFPPVWNPIA
     YLDYNNLWRT IDNMGKEIPT DAPWEAQHAD KWDKMTMKEL IDKICWTKTA RRFAYLFVNI
     NVTSEPHEVS ALWFLWYVKQ CGGTTRIFSV TNGGQERKFV GGSGQVSERI MDLLGDQVKL
     NHPVTHVDQS SDNIIIETLN HEHYECKYVI NAIPPTLTAK IHFRPELPAE RNQLIQRLPM
     GAVIKCMMYY KEAFWKKKDY CGCMIIEDED APISITLDDT KPDGSLPAIM GFILARKADR
     LAKLHKEIRK KKICELYAKV LGSQEALHPV HYEEKNWCEE QYSGGCYTAY FPPGIMTQYG
     RVIRQPVGRI FFAGTETATK WSGYMEGAVE AGERAAREVL NGLGKVTEKD IWVQEPESKD
     VPAVEITHTF WERNLPSVSG LLKIIGFSTS VTALGFVLYK YKLLPRS
//
